不同因素对猪肺炎支原体颜色变化单位测定的影响

为摸清猪肺炎支原体的颜色变化单位(CCU)测定是否受试验相关因素的影响,通过不同培养体系、不同种类的容器、不同的稀释方法测定猪肺炎支原体的CCU,观察培养基的变色情况,最终通过测定各组猪肺炎支原体的CCU来分析不同因素对猪肺炎支原体培养滴度的影响。结果显示,利用不同培养体系、不同容器及不同的稀释方法测定猪肺炎支原体的CCU,其结果差异均不显著(P>0.05)。该研究可为今后支原体的CCU测定提供参考。     

不同容积的培养瓶对猪肺炎支原体培养滴度的影响

本试验将猪肺炎支原体在不同容积的玻璃瓶中进行培养,对各自生长过程中不同时间点的颜色变化单位(CCU)和pH进行测定,分析不同容积的培养瓶对猪肺炎支原体培养滴度的影响。结果显示:与小瓶培养的猪肺炎支原体相比,万瓶的生长速度慢、CCU低、收获菌种的pH范围较广。本试验为猪肺炎支原体大规模培养和疫苗生产提供了参考。     

猪肺炎支原体生长培养基的筛选

为了解猪肺炎支原体的培养特性,筛选出肺炎支原体生长的最适培养基,试验采用颜色改变单位(CCU)计数法和PCR方法对猪肺炎支原体在4种常用培养基及改良KM2培养基中生长情况进行了检测与比较。结果显示:改良的KM2培养基为最适培养基,10天时颜色改变单位可达108CCU/mL。     

蛋白质免疫印迹快速测定猪肺炎支原体抗原含量

为建立快速测定猪肺炎支原体抗原含量的方法,试验应用P46单抗建立不同CCU含量的猪肺炎支原体抗原蛋白免疫印迹图谱,测定不同批次的猪肺炎支原体抗原CCU含量,并与Western blot(WB)测定的CCU进行比较。结果显示:曝光5 s,107 CCU/mL含量以上的猪肺炎支原体抗原在46 kDa处有条带,且条带粗细、明暗程度随着CCU含量的增高而增强;中试生产的7批抗原中,有3批抗原CCU和WB 2种方法测定的含量相同,两批抗原测定的含量基本相同;两批抗原测定的含量有差异,但差值在1.5~5.0倍之间。结果表明,WB可用于猪肺炎支原体抗原含量的快速测定。     

猪支原体肺炎活疫苗(168株)生产工艺关键技术研究

肺炎支原体的培养和保存条件非常苛刻,是疫苗规模化生产的工艺难题。本文针对猪支原体肺炎活疫苗(168株)生产工艺关键技术进行研究。通过培养试验筛选四种培养基配方表明该疫苗株在低血清改良培养基中生长良好;优化发酵培养工艺,使其在发酵罐培养60～70 h的峰值可达到1010CCU/mL;设计筛选该疫苗耐热保护剂和冻干工艺,37℃下保存10 d的耐老化试验结果显示,下降滴度小于100.5CCU/mL。本研究为提供高效、安全和稳定的猪肺炎支原体疫苗产品奠定基础。     

一株猪肺炎支原体的分离鉴定

从全国部分猪场采集到疑似猪支原体肺炎肺组织病料12份,提取DNA进行猪肺炎支原体PCR和多重PCR检测,将病料研磨后分离猪肺炎支原体,最终分离到1株疑似猪肺炎支原体;通过测序分析、形态观察、生化试验、血清学试验证实其为猪肺炎支原体。该菌株能适应人工培养基的培养,且传代生长良好,液体培养基中培养活菌滴度达109CCU/m L;菌株有一定的致病性,免疫原性好,可作为疫苗备用菌株,该菌株的分离鉴定为研制猪支原体肺炎疫苗奠定了基础。     

艾条熏蒸对猪肺炎支原体消毒效果的研究

为了弄清艾条熏蒸对猪舍环境中猪肺炎支原体的消毒效果，试验选择某专业养猪场的相邻两栋猪舍的两个位置等同的栏舍，分为A、B两组，A组采用艾条熏蒸2小时，B组不进行熏蒸。熏蒸结束后通过肺炎支原体浓度的测定来检验艾条熏蒸对猪肺炎支原体的消毒效果。结果表明，艾条熏蒸后猪肺炎支原体的CCU有3～4个数量级的减少。结论：艾条熏蒸对猪舍环境中猪肺炎支原体有较好的消毒效果。     

猪肺炎支原体高密度发酵工艺的研究

为提高猪肺炎支原体发酵培养的滴度,在500L发酵罐基础上,对猪肺炎支原体J株的发酵工艺进行了一系列优化试验,各项发酵培养条件经优化后,发酵支原体的滴度得到了明显提高,发酵滴度可达到1×109CCU/ml以上,本研究为提供高效、安全和稳定的猪肺炎支原体疫苗产品奠定基础.     

3种支原体培养基对猪肺炎支原体CJ株培养效果的比较分析

通过猪肺炎支原体CJ株接种3种猪肺炎支原体培养基后的生长活性研究发现,与其他2种培养基相比,接种改良Friis培养基培养2~3 d含菌量可达到1.0×109~10CCU/m L,具有生长迅速、含菌量高的特点,可用于猪肺炎支原体CJ株的培养。     

猪肺炎支原体DJ-166株高密度发酵工艺优化

猪肺炎支原体培养存在对营养需求严苛、培养难度大、菌液培养滴度不高等问题.本试验开展了一系列改进猪肺炎支原体高密度发酵培养工艺的研究,采用添加15％猪血清的优化CH液体培养基(初始pH为7.8),按5％接种量接种,在发酵罐中培养、pH降到6.7～6.8时收获菌液,菌液培养滴度可达1×1010 CCU/mL.本试验结果对猪...     

Protective effect of vaccination with culture supernate of M. hyopneumoniae against experimental infection in pigs

The protective activity of Mycoplasma hyopneumoniae inactivated vaccine prepared from sedimented whole cells and cell-free culture supernates was evaluated experimentally using hysterectomy-produced, colostrum-deprived pigs in which mycoplasmal pneumonia had been induced. The culture supernate vaccine containing less than 10(1) colour-changing units (CCU)/0.2 ml of M. hyopneumoniae significantly (P < 0.05) reduced the percentage of lung lesions compared to controls (3.2 +/- 3.9 vs. 12.2 +/- 2.2%), whereas the sedimented whole cells vaccine containing 10(10) CCU/0.2 ml of organisms provided variable protection (18.7 +/- 16.5 vs. 12.2 +/- 2.2%). Serum from the pigs vaccinated with culture supernate reacted with six protein bands of 97, 89, 65, 46, 42 and 41 kDa by immunoblot analysis. From these results, we conclude that vaccination with culture supernate of M. hyopneumoniae can provide protection against M. hyopneumoniae infection and that these antigens in the culture supernate may be closely related to the reduction of lung lesions.     

The effect of polyclonal antibody on intracellular calcium increase induced by Mycoplasma hyopneumoniae in porcine tracheal cells

An investigation was undertaken to assess whether polyclonal convalescent and hyperimmune sera obtained from pigs inhibit Mycoplasma hyopneumoniae induced increases in intracellular calcium [Ca2+](i) in ciliated porcine tracheal cells. Basal [Ca2+](i) in the tracheal cells was 97+/-13 nM (n=22 cells in four experiments) and after exposure to M. hyopneumoniae (300 micro g/mL or 10(11) CCU/mL), [Ca2+](i) increased by 246+/-56 nM within 100 s. After pre-treatment with hyperimmune or convalescent serum, M. hyopneumoniae increased [Ca2+](i) by 196+/-43 and 223+/-65 nM, respectively. It was found that neither hyperimmune nor convalescent serum significantly prevented the increase in [Ca2+](i) compared with M. hyopneumoniae alone. It was concluded that polyclonal antibodies produced by mycoplasma vaccination or exposure to the pathogen do not prevent M. hyopneumoniae-induced increase in [Ca2+](i).     

Hemagglutination and hemagglutination inhibition of turkey red blood cells with Mycoplasma hyopneumoniae

The ability of Mycoplasma hyopneumoniae to agglutinate RBC was evaluated to develop an in vitro cytadsorption assay. Using swine RBC in a microtitration hemagglutination test, no agglutination or partial agglutination was detected. Comparison of RBC from various other species indicated that improved hemagglutination was obtained with RBC from turkeys. This hemagglutination was detected only when mycoplasma cells used in the assay had been frozen and thawed, heated at 50 C for 30 minutes, or treated with trypsin. Treatment of RBC with trypsin or neuraminidase enhanced hemagglutination. Possible surface lectin activity in M hyopneumoniae was evaluated by use of carbohydrates in a blocking assay; hemagglutination was not inhibited by any of 13 carbohydrates evaluated. Mycoplasma hyopneumoniae convalescent porcine serum and monoclonal antibodies against 2 M hyopneumoniae immunogens of molecular weights of 64,000 and 41,000 inhibited hemagglutination.     

猪肺炎支原体DJ-166株的分离鉴定

从山西某猪场采集疑似猪支原体肺炎肺组织病料,接种CH培养基培养,克隆纯化获得一株菌株。该菌株经PCR、培养特性、生化特性和血清学特性试验鉴定为猪肺炎支原体,命名为DJ-166株。该分离菌株在人工合成培养基上传8代稳定后,活菌计数达到108CCU/m L;菌液培养物气管注射猪后,致病性较弱;免疫原性试验证明该分离菌株具有良好的免疫原性,此结论为猪支原体肺炎疫苗的研究提供了必要条件。     

Application and field validation of a PCR assay for the detection of Mycoplasma hyopneumoniae from swine lung tissue samples.

A PCR assay was validated for the detection of Mycoplasma hyopneumoniae in porcine lung tissue. The detection limit of the assay was 0.18 colony-forming units/g of lung sample spiked with M. hyopneumoniae. In field validation, 426 pigs from 220 cases were examined for M. hyopneumoniae infection by M. hyopneumoniae PCR and a fluorescent antibody (FA) test. In total, 103 pig lungs (24.2%) were positive in the PCR test, and 69 pig lungs (16.2%) were positive in the FA test, among which, 62 pigs were positive for both PCR and FA test. Most of the PCR-positive but FA test-negative cases had lesions compatible with M. hyopneumoniae infection. With Bayesian modeling, the diagnostic sensitivity and specificity of the PCR were determined to be 97.3% and 93.0%, respectively.     

In vitro stimulation of antibody production to Mycoplasma hyopneumoniae by porcine peripheral blood mononuclear cells.

A method to stimulate and detect the in vitro production of antibodies to Mycoplasma hyopneumoniae by porcine peripheral blood mononuclear cells (PBMC) was established. PBMC were cultured in microtiter plates coated with a sonicated M. hyopneumoniae whole cell antigen and the amount of antibody bound to the coating antigen was determined by an enzyme linked immunosorbent assay (ELISA). In addition, the amount of non-bound antibody was determined by testing the culture supernatants in the ELISA which detects porcine antibodies to M. hyopneumoniae. The production of antibodies, in terms of total absorbance values, was enhanced by including 2.5 ng pokeweed mitogen (PWM) per ml growth medium without altering the specificity of the assay. In a pilot experiment, the applicability of the method to follow the development of antigen-reactive cells during primary and secondary immunizations with M. hyopneumoniae was evaluated. Antigen-reactive cells, identified by their ability to produce antibodies to M. hyopneumoniae in vitro, were detected seven days after the primary immunization and reached their highest antigen reactivity one week later. In comparison, antigen-reactive cells could be detected three days after the booster immunization and remained in the circulation for 2 weeks.